Towards Healthcare Research & Consulting
Plant-Based Excipients Market
Updated Date: 26 June 2026   |   Report Code: 6638

Plant-Based Excipients Market Research Report on Trends and Growth 2035

According to Rohan Patil, who specializes in the pharmaceutical industry with over 5 years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the Plant-Based Excipients Market. The global plant-based excipients market size was estimated at USD 2.09 billion in 2025 and is predicted to increase from USD 2.18 billion in 2026 to approximately USD 3.19 billion by 2035, expanding at a CAGR of 4.32% from 2026 to 2035. His research shows that there is an increase in demand for natural and sustainable ingredients in pharmaceuticals, a growing preference for clean-label formulations, and an increase in the use of plant-based binders, fillers, and disintegrants, as well as improvements in excipient processing technology. In addition, there is increased support from regulation for environmentally friendly manufacturing of pharmaceuticals, an increase in investment in bio-based materials, and an increase in applications of these materials in tablets, capsules, and nutraceuticals are all helping to drive the growth of the market. The study also provides information on the competitive strategies of major players in the industry, such as Roquette Frères, Ashland Inc., Ingredion Incorporated, DFE Pharma, SPI Pharma, and Colorcon Inc., and their impact on the growth of the global market for plant-based excipients. 

Last Updated : 26 June 2026 Category: Pharmaceuticals Insight Code: 6638 Format: PDF / PPT / Excel

Content

1. Executive Summary

  • 1.1. Market Overview
    • 1.1.1. Definition of the Plant-Based Excipients Market
    • 1.1.2. Key Market Trends & Drivers
    • 1.1.3. Market Size and Forecast (2025–2034)
  • 1.2. Key Insights
    • 1.2.1. Growth Rate and Market Value Estimates
    • 1.2.2. Key Opportunities
    • 1.2.3. Key Risks and Challenges

2. Market Overview

  • 2.1. Market Dynamics
    • 2.1.1. Market Drivers
    • 2.1.2. Market Restraints
    • 2.1.3. Market Opportunities
    • 2.1.4. Technological Advancements and Impact
    • 2.1.5. Regulatory Environment and Its Effect on the Market
  • 2.2. Market Structure and Analysis
    • 2.2.1. Market Segmentation Overview
    • 2.2.2. Market Competition and Competitive Landscape
  • 2.3. Value Chain Analysis
    • 2.3.1. Value Chain Impact on Chemical Nature and Applications
    • 2.3.2. Sourcing and Sustainability Factors
    • 2.3.3. Role of Plant-Based Excipients in Drug Development and Formulation

3. Segmentation Analysis

  • 3.1. By Chemical Nature
    • 3.1.1. Carbohydrates
      • 3.1.1.1. Market Size and Forecast
      • 3.1.1.2. Role in Pharmaceutical Formulation
      • 3.1.1.3. Key Applications and Trends
    • 3.1.2. Proteins
      • 3.1.2.1. Market Growth and Adoption
      • 3.1.2.2. Functional Benefits in Drug Formulation
    • 3.1.3. Polymers
      • 3.1.3.1. Market Insights and Growth Trends
      • 3.1.3.2. Key Applications and Market Dynamics
    • 3.1.4. Minerals
      • 3.1.4.1. Market Trends and Forecast
      • 3.1.4.2. Functional Uses and Innovation
    • 3.1.5. Glycosides & Waxes
      • 3.1.5.1. Market Growth and Adoption Rates
      • 3.1.5.2. Functional Benefits in Pharmaceuticals
    • 3.1.6. Esters
      • 3.1.6.1. Market Dynamics and Forecast
      • 3.1.6.2. Key Trends and Applications in Drug Formulation
    • 3.1.7. Ethers & Carboxylic Acids
      • 3.1.7.1. Market Trends and Forecast
      • 3.1.7.2. Applications in Drug Development
    • 3.1.8. Others
      • 3.1.8.1. Emerging Excipients and Market Forecast
      • 3.1.8.2. Novel Plant-Based Excipients in Drug Formulation
  • 3.2. By Applications and Function
    • 3.2.1. Binders & Diluents
      • 3.2.1.1. Market Size and Forecast
      • 3.2.1.2. Functional Benefits in Drug Formulation
    • 3.2.2. Glidants
      • 3.2.2.1. Market Trends and Forecast
      • 3.2.2.2. Applications in Pharmaceutical Production
    • 3.2.3. Lubricants & Disintegrants
      • 3.2.3.1. Market Growth and Adoption Trends
      • 3.2.3.2. Role in Tablet Formulation and Performance
    • 3.2.4. Film Forming & Coating Agents
      • 3.2.4.1. Market Size and Adoption Trends
      • 3.2.4.2. Functional Uses in Drug Development
    • 3.2.5. Plasticizers
      • 3.2.5.1. Market Forecast and Adoption Rates
      • 3.2.5.2. Role in Drug Delivery Systems
    • 3.2.6. Suspended Agents
      • 3.2.6.1. Market Trends and Forecast
      • 3.2.6.2. Functional Roles in Pharmaceutical Products
    • 3.2.7. Preservatives & Antioxidants
      • 3.2.7.1. Market Insights and Trends
      • 3.2.7.2. Applications in Pharmaceutical Formulations
    • 3.2.8. Colorants & Flavoring Agents
      • 3.2.8.1. Market Growth and Adoption
      • 3.2.8.2. Functional and Aesthetic Benefits
  • 3.3. By Region
    • 3.3.1. North America
      • 3.3.1.1. Market Size & Trends (U.S., Canada, Mexico)
      • 3.3.1.2. Adoption Insights and Regional Trends
    • 3.3.2. Europe
      • 3.3.2.1. Market Dynamics and Trends (UK, Germany, France, etc.)
      • 3.3.2.2. Regional Adoption Insights and Growth Drivers
    • 3.3.3. Asia Pacific
      • 3.3.3.1. Market Forecast (Japan, China, India, etc.)
      • 3.3.3.2. Regional Dynamics and Technological Advancements
    • 3.3.4. Latin America
      • 3.3.4.1. Market Insights and Growth Potential (Brazil, Argentina, etc.)
      • 3.3.4.2. Market Drivers and Barriers
    • 3.3.5. Middle East & Africa
      • 3.3.5.1. Market Trends & Forecast (South Africa, Saudi Arabia, UAE)
      • 3.3.5.2. Regional Adoption Trends and Competitive Landscape

4. Cross-Segment Analysis

  • 4.1. Chemical Nature x Applications & Functions
    • 4.1.1. Market Correlations and Growth Insights
    • 4.1.2. Key Cross-Segment Drivers and Challenges
  • 4.2. Applications x Region x End-User
    • 4.2.1. Regional Insights for Key Application Growth
    • 4.2.2. End-User Segment Analysis by Region
  • 4.3. Competitive Landscape across Segments
    • 4.3.1. Company Positioning in Chemical Nature and Applications
    • 4.3.2. Market Share Analysis by Region and Application

5. Competitive Landscape

  • 5.1. Company Profiling
    • 5.1.1. Roquette Frères
    • 5.1.2. BASF Corporation (BASF SE)
    • 5.1.3. Lonza Group AG
    • 5.1.4. DFE Pharma
    • 5.1.5. Evonik Industries AG
    • 5.1.6. Micro Powders, Inc.
  • 5.2. Market Share Analysis
  • 5.3. Strategic Initiatives and Competitive Strategies
  • 5.4. Recent Developments and Key Innovations

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. Market Trends and Growth Drivers
    • 6.1.2. Adoption Insights and Regulatory Landscape
  • 6.2. Europe
    • 6.2.1. Market Dynamics and Growth Potential
    • 6.2.2. Adoption Insights and Regulatory Impacts
  • 6.3. Asia Pacific
    • 6.3.1. Emerging Trends and Opportunities
    • 6.3.2. Technological Developments in the Region
  • 6.4. Latin America
    • 6.4.1. Market Insights and Growth Factors
    • 6.4.2. Competitive Landscape
  • 6.5. Middle East & Africa
    • 6.5.1. Market Dynamics and Growth Forecast
    • 6.5.2. Adoption Trends and Challenges

7. Strategic Insights

  • 7.1. Key Growth Strategies
    • 7.1.1. Market Entry and Expansion Strategies
    • 7.1.2. Product Development and Innovation Insights
  • 7.2. Risk Analysis
    • 7.2.1. Key Risks in Market Growth
    • 7.2.2. Mitigation Strategies
  • 7.3. Opportunities in the Market
    • 7.3.1. New Market Entrants and Innovations
    • 7.3.2. Investment and Acquisition Trends

8. Technology and Regulatory Analysis

  • 8.1. Technological Trends Impacting the Plant-Based Excipients Market
    • 8.1.1. Innovations in Excipients Derived from Plant Sources
    • 8.1.2. Role of Plant-Based Excipients in Sustainable Formulations
  • 8.2. Regulatory Environment
    • 8.2.1. Regulatory Approvals and Compliance in Different Regions
    • 8.2.2. Impact of FDA and EMA Regulations on Plant-Based Excipients
  • 8.3. Pricing Analysis
    • 8.3.1. Pricing Trends and Strategies for Key Excipients
    • 8.3.2. Factors Influencing Pricing in Plant-Based Excipients

9. Market Forecast

  • 9.1. Market Size and Forecast (2025–2034)
    • 9.1.1. Global Market Size and Growth Rate
    • 9.1.2. Market Size by Segment (Chemical Nature, Application, Region, etc.)
    • 9.1.3. Market Share Analysis by Key Companies
  • 9.2. Regional Market Forecast
    • 9.2.1. North America Forecast
    • 9.2.2. Europe Forecast
    • 9.2.3. Asia Pacific Forecast
    • 9.2.4. Latin America Forecast
    • 9.2.5. Middle East & Africa Forecast
  • 9.3. Segment-wise Growth Projections
    • 9.3.1. Chemical Nature Segment Forecasts
    • 9.3.2. Applications and Function Forecasts
    • 9.3.3. End-User Segment Forecasts

10. Strategic Recommendations

  • 10.1. Recommendations for Manufacturers and Suppliers
    • 10.1.1. Investment and Product Development Strategies
    • 10.1.2. Technological Advancements and Integrations
  • 10.2. Recommendations for Investors
    • 10.2.1. High-Growth Segments for Investment
    • 10.2.2. Regional Investment Opportunities
  • 10.3. Recommendations for Policymakers
    • 10.3.1. Regulatory Frameworks and Support for Innovation
    • 10.3.2. Healthcare Accessibility and Adoption Incentives

11. Conclusion

  • 11.1. Summary of Key Findings
    • 11.1.1. Market Growth Trends
    • 11.1.2. Competitive Landscape Insights
    • 11.1.3. Key Technological Developments
  • 11.2. Final Thoughts on Market Opportunities and Risks
    • 11.2.1. Key Opportunities for Stakeholders
    • 11.2.2. Key Risks and Mitigation Strategies

12. Appendix

  • 12.1. Glossary of Terms
  • 12.2. Research Methodology
  • 12.3. List of Figures and Tables
  • 12.4. Additional Resources and References
  • 12.5. Company Profiles of Key Market Players

FAQ's

Answer : The plant-based excipients market is on a steady growth path rising from USD 2.18 billion in 2026 to about USD 3.19 billion by 2035, growing at a 4.32% CAGR.

Answer : North America is currently leading the plant-based excipients market due to strong pharmaceutical and nutraceutical industries, high consumer awareness of natural and clean-label products

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.  

Meet the Team

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar